- 2019 (38) ▼
- 2018 (21) ▼
- 2017 (10) ▼
- 2016 (15) ▼
Orphazme have just announced their interim report detailing their activities and achievements for the first half of 2019 and we’re thrilled about one of their milestones: they have completed enrolment in their Phase II Gaucher clinical trial of arimoclomol which was initiated in June 2018 across 9 centres in India, involving approximately 40 patients.
We look forward to sharing results from this in the first half of 2020.
You can read the full report here https://www.orphazyme.com/news-feed/2019/8/28/orphazyme-announces-interim-report-first-half-2019